Immune intervention reduces beta-cell death in type 1 diabetes
(HealthDay)—Patients recently diagnosed with type 1 diabetes have greater death of pancreatic β-cells compared with patients with long-standing diabetes, which can be reduced by treatment with teplizumab, according to ...
Feb 26, 2013
0
0